The Current Ratio as of December 2024 (TTM) for Praxis Precision Medicines, Inc. (PRAX) is 10.96

According to Praxis Precision Medicines, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.96. This represents a change of -2.42% compared to the average of 11.23 of the last 4 quarters.

Praxis Precision Medicines, Inc. (PRAX) Historical Current Ratio (quarterly & annually)

How has PRAX Current Ratio performed in the past?

The mean historical Current Ratio of Praxis Precision Medicines, Inc. over the last ten years is 7.63. The current 10.96 Current Ratio has changed 14.26% with respect to the historical average. Over the past ten years (40 quarters), PRAX's Current Ratio was at its highest in in the June 2021 quarter at 22.08. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Praxis Precision Medicines, Inc. (PRAX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Praxis Precision Medicines, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Praxis Precision Medicines, Inc. (PRAX) Average Current Ratio

How has PRAX Current Ratio performed in the past?

The current Current Ratio of Praxis Precision Medicines, Inc. (PRAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Praxis Precision Medicines, Inc. (PRAX) Current Ratio vs. Peers

How is PRAX’s Current Ratio compared to its peers?

Praxis Precision Medicines, Inc.’s Current Ratio is less than Molecular Partners AG (14.33), greater than Mineralys Therapeutics, Inc. (8.55), greater than AN2 Therapeutics, Inc. (9.75), less than Pharvaris N.V. (19.08), greater than PepGen Inc. (8.47), less than Theseus Pharmaceuticals, Inc. (29.93), less than PMV Pharmaceuticals, Inc. (13.98), less than Cullinan Oncology, Inc. (24.46), less than Enliven Therapeutics, Inc. (17.44), greater than Immuneering Corporation (7.99), greater than Anebulo Pharmaceuticals, Inc. (3.45), less than Eliem Therapeutics, Inc. (0), greater than HCW Biologics Inc. (0.07), greater than Stoke Therapeutics, Inc. (5.09), less than Edgewise Therapeutics, Inc. (26.35), less than Crinetics Pharmaceuticals, Inc. (16.38), less than Dyne Therapeutics, Inc. (17.02), less than Revolution Medicines, Inc. (14.24),

Build a custom stock screener for Praxis Precision Medicines, Inc. (PRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Praxis Precision Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Praxis Precision Medicines, Inc. (PRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Praxis Precision Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.